Vascular program
16:00 - 17:30Abstract session I: CAROTID I
Hall: Mediteraneo + Adriatic
Moderators: Ionel Droc (Romania), D.Milic (Serbia)
Key Note Lecture: What evidence are we missing in carotid field? R. Bulbulia (UK) 7 minutes
Key Note Lecture: Emergency surgery for carotid occlusion, Ugur Bengisun (Turkey) 7 minutes
1. Shunting during carotid endarterectomy: Is it safe? Lessons learned from diffusion-weighted magnetic resonance imaging, P. Lerut (Belgium)
2. The feasibility of surgical treatment in patients with type II internal carotid artery occlusion, S. Babic (Serbia)
3. The immediate and intermediate results of staged carotid endarterectomy and coronary artery bypass grafting, V. G. Tsoi (Russian Federation)
4. Endovascular treatment of carotid artery disease – experience from Serbian clinical centre, V. Cvetic, (Serbia)
5. Operative repair of extracranial carotid aneurysms based on anatomic types and kinks, M. Sevkovic )Serbia)
6. Coexistence of internal carotid artery stenosis in patients with abdominal aortic aneurysm, M. Vranes Stojimirov (Serbia)
7. Chronic symptomatic internal carotid artery occlusion – conservative, endovascular or surgical treatment, M. Gasparini (Slovenia)
8. MicroNet covered stent in the treatment of vulnerable carotid plaque: short and mid-term results, M. Sponza (Italy)
9. Actual strategy in asymtomatic carotid stenosis: a single centre experience, I. Droc (Romania)
16:00 - 17:30Abstract session II: AORTIC DISEASE I
Hall: Aegean + Baltic
Moderators: George Kouvelos (Greece), Dusan Kostic (Serbia)
Key Note Lecture: Optimal treatment for ruptured abdominal aortic aneurysm, Dusan Kostic (Serbia) 9 min
1. Thoracic aorta redo surgery: how to do it, M. Cherchi (Italy)
2. Prospective evaluation of post implantation inflammatory response after EVAR for AAA. Influence on patients one-year outcome, G. Kouvelos (Greece)
3. Renal function impairment in patients undergoing evar versus open repair, K. Spanos (Greece)
4. An aggressive strategy of iliac limb deployment may reduce iliac related secondary interventions after EVAR, M. P. Borrelli (Italy)
5. Retrospective endoleak type 1A outcome is independent of endograft sizing methods, V. C. Buijs (Netherlands)
6. The petticoat technique using the e-xl endograft in the treatment of acute type b aortic dissection, F. Squizzato (Italy)
7. Early and late failure of EVAR – surgical and endovascular solution, J. Molacek (Czech Republic)
8. Inflammatory abdominal aortic aneurysm - special challenge for surgeons or not?, S. Cvetkovic (Serbia)
17:45 - 19:00VASCULAR CINEMA I
Hall: Aegean + Baltic
Moderators: A.Siani (Italy), N.Ilic (Serbia)
Video presentation of procedures for particular pathology with authors’ commentary
1.Evidence based laparotomy closure - PRINCIPLES technique, I.Koncar (Serbia)
2. Endovasscular treatment of total chronic aortic occlusions, N. Mangialardi (Italy)
3. Open repair of thoracoabdominal aneurysm, G.Sokurenko (Russia)
4. Early results of simultaneous carotid and vertebral revascularisation, M. Shatakhyan (Armenia)
4. Early results of simultaneous carotid and vertebral revascularisation, M. Shatakhyan (Armenia)
5. Viabhan Padova Sutureless Technique: Long-Term Results In The Treatment Of Peripheral Arterial Disease, S. Bonvini (Italy)
6. CFDVASC – software for the quantitative and biomechanical analysis of abdominal aortic aneurisms, Z.Milosevic (Serbia)
7. Right renal cell carcinoma with tumor thrombus in inferior vena cava extending into the right atrium: video presentation, A. Tomic, (Serbia)
18:00 - 19:30EC meeting Hall: Sava
Vascular program
08:00 - 09:30Abstract session III: VEINS
Hall: Atlantic II
Moderators:A. Giannoukas (Greece); Z. Maksimovic (Serbia)
Key Note Lecture: The recent guidelines on DVT &PE. K.Ozisik (Turkey), 9 minutes
1. Chronic venous insuffiency and subsequent adverse cardiovascular event, P. Bondarenko (Russian Federation)
2. Elevated gamma glutamyl transferase levels are associated with the location of acute pulmonary embolism. Cross-sectional evaluation in hospital setting, Ö. Korkmaz (Turkey)
3. Effects of rosuvastatin as an adjuvant treatment for deep vein thrombosis, E. M. San Norberto (Spain)
4. Prevention, diagnosis and treatment of venous insufficiency during pregnancy and breastfeeding, M. Kabic Stakic (Serbia)
5. The use of mini-invasive technologies for the treatment, V. Starodubstev (Russian Federation)
6. Duplication of great saphenous vein can change approach during laser ablation, V. Jokovic (Serbia)
7. Cryo Laser and Cryo Sclerotherapy (CLaCS) for the treatment of spider veins and telangiectasias, P. Dragic (Serbia)
8. Endovascular treatment of varicose veins using steam poulses, I. Droc (Romania)
9. Quality-of-life assessment in patients after endovenous laser therapy and conventional surgery using VCSS (Venous Clinical Severity Score), R. Vlachovsky (Czech Republic)
10. Comparison of three different endovenous ablation techniques for treatment of varicose veins, A. B. Budak (Turkey)
08:00 - 09:30Abstract session IV: CAROTID II Hall:Adriatic
Moderators:J.Molacek (Czech Republic); N.Ilijevski (Serbia)
Key Note Lecture: The need for a uniform definition of "index event" in reporting timing of intervention, GJ de Borst, (Netherlands), 7 minutes
1. Urgent carotid endarterectomy: our opinion, G. Sokurenko (Russian Federation)
2. Treatment of simultaneous carotid disease and intracranial aneurysms, P. Matic (Serbia)
3. Predictive value of morphology of circle of Willis on hyperperfusion syndrome after carotid endarterectomy in asymptomatica patients, V. Manojlovic (Serbia)
4. Relationship between calcification and vulnerability of the carotid plaques, L. Ferrante (Italy)
5. Treatment Strategies for Carotid Artery Aneurysms, I. Koncar (Serbia)
6. Cerebral ischaemia in carotid disease relates to carotid plaque volume, E. Katsogridakis (Greece)
7. Endovascular Therapy in Acute Ischemic Stroke; a Single center experience, V. Gavrilovic (Italy)
8. Significant association between annual hospital volume and the risk of in-hospital stroke or death after carotid endarterectomy, but not following carotid stenting, A. Kuehnl (Germany)
9. Variability of origin of the supra-aortic vessels from the aortic arch, D. Mazzaccaro (Italy)
08:00 - 09:30Abstract session V: PERIPHERAL ARTERY DISEASE Hall:Aegean
Moderators:T. Ulus (Turkey), V. Popovic(Serbia)
Key Note Lecture: Vascular disease in diabetic patients: What is different? T. Ulus (Turkey)10 minutes
1. Clinico-pathological assessment of vascular lesions in complicated diabetic foot, M. Elsharawi (Saudi Arabia)
2. Bellow-knee bypasses using vein cuffs our results, . Tomic (Serbia)
3. Design of a new risk score in critical limb ischaemia: the ERICVA model, C. Vaquero (Spain)
4. Factors associated with healing process in diabetic patients with foot ulceration and evaluation of quality of life, K. Spanos (Greece)
5. Distinctive peculiarity and influence of a metabolic syndrome on the course of a peripheral arterial disease at women, P. Bondarenko (Russian Federation)
6. Efficacy of dorsalis pedis artery bypass for limb salvage in patients with critical limb ischemia, N. Petrovic (Malta)
7. Diagnostics of early thrombosis in superficial femoral artery prosthetic bypass using the ankle brachial index, V. Markovic (Serbia)
8. Primary aortic stenting in subtotal aortic occlusion: long-term results, T. Cohnert (Austria)
9. Indications and technical aspects of ultradistal bypass surgery, K. Kerin (Slovenia)
10. Panta rhei in vascular surgery: Hybrid procedures in patients with critical lower limb ischemia, M. Gorlitzer (Austria)
11. Clinical outcome of popliteal artery aneurysms treated with a heparin-bonded stent graft, B. Golchehr (Netherlands)
09.30-10.00 Coffee Break
Coffee with SANOFI
10:00 - 12:30COMMON INTERDISCIPLINARY SESSION
Hall: Pacific
15+5 minutes
Chairman:O. Oto (Turkey)
Moderators:
V. Treska (Czech Republic), T.Folliguet (France), M. Zembala (Poland), L. Davidovic (Serbia)
1. Smoking and cardiovascular death, Sir R.Peto (UK)
2. New developments in the surgical treatment of mitral valve disease – G. Speziali (Italy)
3. What has changed in new guidelines for treatment of thoracic aortic disease (ESVS, ESC) – S. Debus (Germany)
4. Strategy for malpefusion in dissection, H.Jakob(Germany)
5. Treatment of aortic arch disease, R. Chiesa (Italy)
6. New developments in circulatory support circulation for both cardiac and vascular surgeons, S.Schueler (UK)
7. Results of treatment of thoracoabdominal aortic aneurysm repair outside my hospital, M. Jacobs (The Netherlands)
8. Hybrid revascularization in multy vessels coronary disease, data from prospective randomized trial POLMIDES, M.Zembala (Poland )
12:30 - 13:00LERICHE LECTURE
Hall: Pacific
Introduction: S.Schueler
Minimally Invasive Cardiac Surgery: Quo Vadis? O. Oto (Turkey)
13:00 - 14:00Lunch Symposium: UNESCO Bioehics Issues Hall: Pacific
Moderators: D. Palombo (Italy), G. Milasinovic (Serbia)
1. Unesco Book presentation. "Bioethical Issues in Cardiovascular Surgery", D. Palombo (Italy)
2. FFP: Fabication, falsificaton and plagiarism, the three capital sins of scientific research, E. Bucci (Italy)
3. Serbian National commission for collaboration with UNESCO G. Milasinovic (Serbia)
4. Final comments, D. Palombo (Italy)
13:00 - 14:00Lunch Symposium: Mechanical thrombectomy Hall: Atlantic I + II
1. Mechanical debulking in arteries of the lower limband its importance in optimisation of endovascular therapy, M. Bulvas (Czech Republic)
2. Successful recanalisation of venous occlusions with Aspirex ® S mechanical thrombectomy, T. Heller (Germany)
3. Live Case: Clinic for Vacular and Endovascular Surgery, M. Bulvas (Czech Republic), I. Koncar (Sebia)
13:00 - 14:00Lunch Symposium: Veins for lunch Hall: Aegean + Baltic
Moderators: F. Zernovicky (Slovakia), P. Dragic (Serbia)
1. RF ablation, F. Zernovitsky (Slovakia)
2. Laser ablation, P. Dragic (Serbia)
3. Robotic Glue Implementation: A Paradigm Shift, O. Oto (Turkey)
14:00 - 16:00VASCULAR SYMPOSIUM: CAROTID ARTERY DISEASE Hall: Atlantic I, II
Moderators: A.Halliday (UK), FE Fernandes (Portugal), F. Grego (Italy), Radak D. (Serbia)
Lectures: 12+3 min
1. Common carotid practice in 2015 - information from VASCUNET? - C. Setacci (Italy)
2. Factors that are influencing results of CEA in patients with acute stroke. C. Liapis (Greece)
3. Collaboration in asymptomatic carotid trials – the important questions and how ACST 2, SPACE 2 and CREST 2will provide the answers we need – A.Halliday (UK)
4. Retinal infarcts after carotid intervention in asymptomatic patients should be used as surrogate end point in future trials– A. Giannoukas (Greece)
5. Prospective Carotid Data Base analysis: what we discovered after 14.000 eversion endarterectomies?Dj. Radak (Serbia)
6. New findings from the ACSRS study group–FE.Fernandes (Portugal)
7. Is stent cells design affect outcome after Carotid Artery Stenting?-M. Matsagkas (Greece)
Debate: Which neurological monitoring is optimal for carotid surgery.
- Cervical block/Remiphentanil anesthesia – G.Marccucci( Italy)-7 min
- TCD, EEG, TCO – F. Grego ( Italy)-7 min
VOTING
VOTING
16:30 - 18:00Abstract session VII: TEVAR Hall: Aegean
Moderators:F. Grego (Italy), I.Koncar (Serbia)
Key Note Lecture: What is the role of Endovascular treatment of uncomplicated type B dissection S. Trimarchi (Italy), 9 minutes
1. Intra- aortic tumor-like mass, F. Urgnani (Italy)
2. Health related quality of life to evaluate long term outcome afterleft subclavian artery overstenting during TEVAR, L. Di Tommaso (Italy)
3. Thoracic endovascular surgery for traumatic aortic injury:a fifteen-years single center experience, L. Di Tommaso (Italy)
4. Early results of big diameter Bare Stentsin endovascular treatment of aortic dissection, A. Kazimierczak (Poland)
5. Prognostic value of multi-slice computed tomography in patients with acute aortic dissection type III, N. F atic (Serbia)
6. Aortic mobile thrombi of the descending aorta leading to acute limb ischemia: endovascular treatment, M. T. Occhiuto (Italy)
7. Efficacy of surgical and endovascular supraaortic debranching for TEVAR at zone 1, R. Akchurin (Russian Federation)
8. Outcomes of hybrid vs total endovascular repair in the treatment of aortic arch aneurysm, F. Squizzato (Italy)
9. Outcomes of endovascular treatment of acute aortic syndrome, F. Squizzato (Italy)
Outcome after branched endovascular aortic repair for thoracoabdominal aortic aneurysms treated by single step or staged procedures with aneurysm sac perfusion, R. Kopp (Germany)
16:30 - 18:30VASCULAR YOUNG AWARD SESSION Hall: Pacific
Chairman:V. Treska (Czech Republic)
Jury:D. Palombo (Italy), P. Kasprzak (Germany),T. Ulus (Turkey); L. Davidovic (Serbia)
Abstract presentations 6+2 min
1. Could endogenous markers predict the outcome and prognosis of patient with abdominal aortic aneurysm? Single centre study, K. Houdek (Czech Republic)
2. Degree of contralateral carotid stenosis improves preoperative risk stratification of patients with asymptomatic ipsilateral carotid stenosis, J. Basic (Austria)
3. Urgent Carotid Endarterectomy is Safe and Effective Treatment for Patients with Acute Neurological Ischemic Events, M. Neskovic (Serbia)
4. Morphological differencesof the aortoiliac segment in patients of Caucasian and Asian origin with abdominal aortic aneurysm, M. Brankovic (Serbia)
5. Innovative technique for paraanastomotic leak closure after type I aortic dissection repair; Endovascular stent graft implantation to ascending aorta, M. Akbulut (Turkey)
6. Preoperative Intrasac Thrombus Load Predicts Worse Outcome After Elective Endovascular Repair of Abdominal Aortic Aneurysms, N. Montelione (Italy)
7. Should We Reassess the Risk Factors for Peripheral Vascular Disease?, R. Stefana (Romania)
8. Role of Contrast Enhanced Ultrasound in the Follow-up of EVAR with Branched and Fenestrated Endografts, F. B. Calinescu (Romania)
9. Clinical presentation, surgical management and outcomes of anastomotic versus non-anastomotic dialysis access aneurysms, M. Z. Ghariani, (Tunisia)
10. 4,5-Year Follow-Up After Carotid Bifurcation Resection and Interposition Of A Polytetrafluorethylene Graft. A Retrospective Study of 49 Consecutive Procedures, I. Diebels (Belgium)
11. Endovascular aneurysm repair: risk factors for limb occlusion, A.Vinha (Portugal)
16:30 - 18:30BEST VASCULAR POSTER SESSION Hall: Tisa
Moderators: V. Palmiste (Estonia), A.Tomic (Serbia)
1. Using „cormatrix“material as a patch for profundoplasty, A. Tomic (Serbia)
2. Incidence of contrast induced nephropathy in patients treated with endovascular aortic repair, E. M. San Norberto (Spain)
3. Selecting approach in open repair of popliteal artery aneurysm, M. Sladojevic (Serbia)
4. Comparative evaluation of immediate results of surgical treatment of ischemic heart disease and defeats of brachiotcephalic arteries, A. Yulbarisov (Uzbekistan)
5. Preliminary results of radiofrequency vein ablation programme at Mater Dei Hospital Malta, I. Said (Malta)
6. Acute thrombosis of both internal carotid arteries following endarterectomy of the right internal carotid artery, S. Pecanic (Croatia)
7. Urgent open surgical treatment of thoracic aortic expansion following acute type b dissection-single center expirience, I. Marjanovic (Serbia)
8. Midterm follow-up of endovascular treatment of peripheral arterial disease in elderly patients, H. S. Gedik (Turkey)
9. Thoracic duct injury after subclavian artery aneurysm reconstruction- surgical or conservative treatment?, I. Marjanovic (Serbia)
10. Transjugular, transcaval coil embolization of an aaa in marfan's syndrome, M. Aleksic (Germany)
11. Below the knee interventions, single-center case series, B. Lukic (Serbia)
12. Aortoaortic bypass following infection of descending thoracic aorta graft, R. Abdulgasanov (Russian Federation)
13. Finite element analysis of uncommonly hlarge renal arteriovenous malformation, L. Velicki (Serbia)
14. Computational simulation of blood flow in the abdominal and left common iliac aneurysm with and without stent graft, S. Djorovic (Serbia)
15. Stepwise Total Aortic Treatment of Combination of Open Surgery and Fenestrated Endografts for a Dissecting Thoracoabdominal Aneurysm in a Patient with Loeys-Dietz, M. Honda (Japan)
16. Ultrasound Measurement Carotid Arterial Stiffness and Estimation in Strain RateOur Experience, D. Vasic (Serbia)
17. Evaluation of the renal function using serum Cystatin C following open and endovascular aortic anuerysm repair, P. Mutavdzic (Serbia)
18. Treating Uncomplicated Type B Aortic Dissection with TEVAR: From Elective Procedure to Emergency Surgery, M. Planinc (Croatia)
19. Side-limb conduit used for distal aortic perfusionduring open thoracoabdominal aortic aneurysmrepair, T. Mestrovic (Croatia)
20. Case report: hybrid treatment of aortoenteric fistula in Type I endoleak post EVAR, . Spina (italy)
21. ” Laser crossectomy” further steep in endovenous termal ablation - single center experience using radial fiber and diode 1470nm laser, P. Dragic (Serbia)
22. Mid-term results of distal lower limbs revascularizations, M. Z. Ghariani (Tunisia)
23. Mid-term results of upper limb revascularizations, M. Z. Ghariani (Tunisia)
24. Takayasu arteritis from MDCT perspective – our expirience, M. Vuckovic (Serbia)
25. Mid-term results of subclavian artery transposition, M. Z. Ghariani (Tunisia)
26. Acute aortic syndrome - what radiologist needs to know D. Zoric (Serbia)
27. Hybrid revascularisation of lower limb ischaemia, V. Popovic (Serbia)
28. Popliteal entrapment, an unusual case of lower limb ischemia in young patients: a rare case of twins, M. tatafiore (Italy)
29. Surgical management outcomes of infectious versus non-infectious dialysis access aneurysms, M. Z. Ghariani (Tunisia)
16:30 - 18:00Abstract session VI: MISCELLANEOUS Hall: Adriatic
Moderators:C. Houdek (Czech Republic), I. Cinara (Serbia)
Key Note Lecture: Tissue reconstruction after leg revascularization M. Ionac (Romania) 9 minutes
1. Topical autologous fibrin sealants for primary prevention of groin wound and prosthetic graft complications following, S. Pejkic (Serbia)
2. Iatrogenic arterial injuries, A. Dimic (Sebia)
3. Cardiometabolic risk factors and the development of infectious process among patients after reconstructive surgeriesfor atherosclerosis of main arteries, A. Artemova (Russian Federation)
4. Cryopreserved homografts for in situ repair of the complex vascular infections, M. Petrunic (Croatia)
5. Early diagnosis of infectious complications in vascular surgeries, R. Abdulgasanov (Russian Federation)
6. Vacuum-assisted closure therapy for Szilagi II and Szilagi III groin infections, P. Jovanovic (Serbia)
7. First experience of US guided percutaneous embolization of femoral pseudoaneurysms using D-STAT, C. Maturi (Italy)
8. Long-term results of open and endovascular treatment of visceral artery aneurysms, W. Dorigo (ITaly)
9. Visceral artery aneurysms (VAA) single center case series in endovascular treatment using up-to-date materials, based on 11 patients during the past 2 years, M. Sponza (Italy)
10. Use of Cormatrix patch in cardiovascular procedures, T. Klokocovnik (Slovenia)
Cardiac program
08:00 - 09:30Abstract session II: MITRAL VALVE SURGERY
Hall: Mediteran
Moderators: T.Folliguet (France); I.Stojanovic (Serbia)
Key Note Lecture: Trans apical Neochords early experience, A. Colli (Italy) 9 minutes
1. Preserved posterior valve prevents to embed the catheter during transapical peripreosthetic mitral leakage closure, F. Cingoz (Turkey)
2. Midterm outcomes of chordal cutting in combination with downsized ring annuloplasty for mitral regurgitation, Erkengel (Turkey)
3. Comparative assessment of mitral valve repair with rigid ring and synthetic strip. Whether it is possible to unify procedure?, G. Antipov (Russian Federation)
4. Severe intravascular hemolysis and acute renal failure following a valve replacment, S. Göksel (Turkey)
5. Mitrofix™ Restoration Concept for ischemic mitral valve regurgitation, T. Adademir (Turkey)
6. Starting a robotic mitral valve surgery program: early experience and current knowledge on the topic, N. F. Bayard (France)
7. Early and mid term outcome in patients undergoing redo mitral valve surgery. A single center experience, E. Prifti (Albania)
8. Predictors of hospital mortality in a European multicenter redo mitral surgical experience: inferences for future transcatheter mitral procedures, RECORD Investigators from Italy, Germany, France, UK, Finland
9. Supraanular implantation of mechanical arteficialmitral valve in case of extreme, R. Ilic (Serbia)
1. Preserved posterior valve prevents to embed the catheter during transapical peripreosthetic mitral leakage closure, F. Cingoz (Turkey)
2. Midterm outcomes of chordal cutting in combination with downsized ring annuloplasty for mitral regurgitation, Erkengel (Turkey)
3. Comparative assessment of mitral valve repair with rigid ring and synthetic strip. Whether it is possible to unify procedure?, G. Antipov (Russian Federation)
4. Severe intravascular hemolysis and acute renal failure following a valve replacment, S. Göksel (Turkey)
5. Mitrofix™ Restoration Concept for ischemic mitral valve regurgitation, T. Adademir (Turkey)
6. Starting a robotic mitral valve surgery program: early experience and current knowledge on the topic, N. F. Bayard (France)
7. Early and mid term outcome in patients undergoing redo mitral valve surgery. A single center experience, E. Prifti (Albania)
8. Predictors of hospital mortality in a European multicenter redo mitral surgical experience: inferences for future transcatheter mitral procedures, RECORD Investigators from Italy, Germany, France, UK, Finland
9. Supraanular implantation of mechanical arteficialmitral valve in case of extreme, R. Ilic (Serbia)
08:00 - 09:30Abstract session I: AORTIC VALVE SURGERY
Hall: Atlantic I
Moderators: F.Doguet (France), M. Vranes (Serbia)
Key Note Lecture: Minimal invasive aortic valve replacement – is there enough evidence to support it? M.Vola (France), 9 minutes
1. Technical tips and tricks for the heart valve surgery through a mini-sternotomy approach, P. Kovacevic (Serbia)
2. Predictive factors of 12-year survivalin octogenarians following aortic valve replacement: a retrospective comparison with same-aged general population, F. Terrieri (Italy)
3. Our experiences of aortic valvular reconstruction (carvar technique), M. Djordjevic (Slovenia)
4. Excellent results of minimally invasive aortic valve replacement through j-sternotomy: single-center experience with over 400 cases, M. Kaczmarczyk (Poland)
5. Surgical treatment of poststenotic aneurysms of ascending aortaduring correction of aortic valve disease, V. Popov (Ukraine)
6. Automatic planning and simulation for minimally invasive approach to the aortic valve, V. G. Ruggieri (France)
7. Development of a novel autologous bioprosthesis, J. Takewa (Japan)
8. In which low- or intermediate-risk patient redo-aortic valve surgery is futile? Indications for transcatheter procedures from a multicenter European “record” (redo cardiac operation research database) initiative, F. Onorati (Finland)
9. The development of a new physiological flow chamber for the investigation of artificial aortic valves, D. Dohle (germany)
10. The place for homografts in aortic valve replacement surgery, V. Podpalov (Belarus)
11. Carotid Versus Axillary Artery Cannulation for Acute Aortic Dissection Type, A. Aleksic (Germany)
08:00 - 09:30Abstract session III: TRANSCATHETER AORTIC VALVE REPLACEMENT
Hall:Baltic
Moderators: M.Thielmann (Germany), M. Peric (Serbia)
Key Note Lecture: Overview of current practice, M. Thielmann (Germany) 9 minutes
1. Impact of trans-catheter aortic valve implantation on mitral regurgitation at mid-term follow-up, E. Senanayake (United Kingdom)
2. Does trans-catheter aortic valve implantation improve LV function at short-term follow-up?, E. Senanayake (United Kingdom)
3. Sutureless-AVR versus TAVI: clinical outcome and costs matching, G. Santarpino (Germany)
4. Anesthesia for TAVI, Z. Valuh (Slovakia)
5. Impact of previous coronary artery bypass grafting in patients undergoing transcatheter aortic valve implantation, S. E. Shehada (Germany)
6. Imaging in Transcatheter Aortic Valve Replacement – The role of radiologist, . Petkovic (Serbia)
7. Infectious complications after transcatheter aortic valve implantation or surgical aortic valve replacement, D. Wendt (Germany)
8. Transapical Transcatheter Aortic Valve Implantation in Pure Aortic Regurgitation: Mid-Term Outcomes, D. Wendt (Germany)
9. Access Site Vascular Complicationsin Patients Undergoing Transfemoral Transcatheter Aortic Valve ImplantationVia Open Versus Percutaneous Approaches, R. Walas (Poland)
10. Effect of anti-embolic filter protection on brain injury during transcatheter aortic valve implantation, S. Knipp (Germany)
1. Impact of trans-catheter aortic valve implantation on mitral regurgitation at mid-term follow-up, E. Senanayake (United Kingdom)
2. Does trans-catheter aortic valve implantation improve LV function at short-term follow-up?, E. Senanayake (United Kingdom)
3. Sutureless-AVR versus TAVI: clinical outcome and costs matching, G. Santarpino (Germany)
4. Anesthesia for TAVI, Z. Valuh (Slovakia)
5. Impact of previous coronary artery bypass grafting in patients undergoing transcatheter aortic valve implantation, S. E. Shehada (Germany)
6. Imaging in Transcatheter Aortic Valve Replacement – The role of radiologist, . Petkovic (Serbia)
7. Infectious complications after transcatheter aortic valve implantation or surgical aortic valve replacement, D. Wendt (Germany)
8. Transapical Transcatheter Aortic Valve Implantation in Pure Aortic Regurgitation: Mid-Term Outcomes, D. Wendt (Germany)
9. Access Site Vascular Complicationsin Patients Undergoing Transfemoral Transcatheter Aortic Valve ImplantationVia Open Versus Percutaneous Approaches, R. Walas (Poland)
10. Effect of anti-embolic filter protection on brain injury during transcatheter aortic valve implantation, S. Knipp (Germany)
9.30-10.00h. Coffee Break
Coffee with SANOFI
Coffee with SANOFI
10:00 - 12:30COMMON INTERDISCIPLINARY SESSION Hall: Pacific
15+5 minutes
Chairman:O. Oto (Turkey)
Moderators:
V. Treska (Czech Republic), T.Folliguet (France), M. Zembala (Poland), L. Davidovic (Serbia)
1. Smoking and cardiovascular death, Sir R.Peto (UK)
2. New developments in the surgical treatment of mitral valve disease, G. Speziali (Italy)
3. What has changed in new guidelines for treatment of thoracic aortic disease (ESVS, ESC), S. Debus (Germany)
4. Strategy for malpefusion in dissection, H.Jakob (Germany)
5. Treatment of aortic arch disease, R. Chiesa (Italy)
6. New developments in circulatory support circulation for both cardiac and vascular surgeons, S.Schueler (UK)
7. Results of treatment of thoracoabdominal aortic aneurysm repair outside my hospital, M. Jacobs (The Netherlands)
8. Hybrid revascularization in multy vessels coronary disease, data from prospective randomized trial POLMIDES, M.Zembala (Poland )
12:30 - 13:00LERICHE LECTURE Hall: Pacific
Introduction: S.Schueler
Minimally Invasive Cardiac Surgery: Quo Vadis? O. Oto (Turkey)
14:00 - 16:00CARDIAC SYMPOSIUM: AORTIC VALVE REPAIR
Hall: Pacific
Moderators: E.Lansac (France), I.Rudez (Croatia), Z.Jonjev (Serbia) Lectures: 15+5 min
1. Aortic annuloplasty to standardize aortic valve repair, E.Lansac (France),
Discussant T. Folliguet
2. Guidelines and roadmap echo analysis for aortic valve repair, A. Berrebi (France)
Discussant: D. Kalimanovska-Ostric (Serbia)
3. Bicuspid repair according to aorta phenotype, J.Vojacek (Czech Republic)
Discussant M. Thielmann
4. How to start aortic valve repair program, I.Rudez, (Croatia)
Discussant O.Oto
5. How to manage residual aortic insufficiency, J.Hulin (Belgium)
Discussant F.Doguet (France)
6. Reimplantation - the best start line for perfect reconstruction of tri(bi)cuspid aortic valve, J. Benedik (Germany)
Discussant Z. Jonjev (Serbia)
14:00 - 16:00CARDIAC SYMPOSIUM: LVAD
Hall: Atlantic I+II
Moderators: S.Schueler (UK) , Z.Sutlic, (Croatia); M.Ristic (Serbia)
Lectures: 10+3min
1. The cardiac allocation score. A new way to allocate donor hearts in Eurotransplant J. Smits (Netherlands)
2. Destination therapy for HF patients: The Leiden Model, H.F.Verway, (Netherlands)
3. The fast and successful set up of transplant and assist program in Belgrade, M.Ristic, (Serbia)
4. ECMO following the heart transplant, A. Zuckermann (Austria)
5. Very early results for HM III, the Astana experience, Y.Pya (Kazahstan)
6.Marginal indications and results for LVAD implantation, Z.Sutlic (Croatia)
7. Stroke and LVAD, E.Flecher (France)
8. Progressing in long term LVAD therapy update on international outcomes , D.Zimpfer (Austria)
16:30 - 18:00Abstract session IV: HEART TRANSPLANTATION, ECMO and LVAD
Hall: Baltic
Moderators: S.Schueler (UK), M.Borojevic (Serbia), K. Kurali (Turkey)
Key Note Lecture: From anecdotal cases to mainstream application of durable devices. S.Schueler (UK) 9 minutes
1. Two-year experience in heart transplant and continuous – flow left ventricular assist device in Serbia, E. Nestorovic (Serbia)
2. Extracorporeal membrane oxygenation as a bridge to definitive cardiac operation in critically ill patients, N. Dobrilovic (USA)
3. Early clinical results for post-approval HeartMate 3 left ventricular assist device implantation – Astana experience, Y. Pya (Kazakhstan)
4. Heart transplantation in University Hospital Dubrava Zagreb: 20 years of experience, M. Planinc (Croatia)
5. Left ventricular assist device-related infection: prevention, treatment and outcome, D. Terzic (Serbia)
6. Retrograde crystaloid cardioplegia for isolated mitral valve replacement, V. Popov (Ukraine)
7. The importance of ventricle and pulmonary mechanical support with IABP and ECMO for a patient bridging to redo coronary bypass surgery, . Gurbuz (TUrkey)
8. Management of upper limb hypoxia in peripheral veno-arterial ECMO, O. Gokalp (Turkey)
9. MDCT imaging of left ventricule assist device, N. Menkovic (Serbia)
10. Extracorporeal membrane oxygenation: experience in primary graft dysfunction after heart transplantation, N. Bradic (Croatia)
16:30 - 18:00Abstract session V: MISCELANEOUS I
Hall: Mediteranean
Moderators: Ihsan Bakir (Turkey), P.Kovacevic (Serbia)
Key Note Lecture: Robotics in cardiac surgery, Ihsan Bakir (Turkey) 9 minutes
1. Our surgical strategy in a patient with mid-septal obstructive hypertrophic cardiomyopathy and coronary artery disease, L. Yilik (Turkey)
2. Fifteen-year experience in using synthetic patches "basex" for management of post-infarction lv aneurysm of heart, R. Abdulgasanov (Russia)
3. Predictors for hospital readmission after cardiac surgery, . Redzek (Serbia)
4. Comparison of the capacity to predict early mortality in patients undergoing cardiac surgery of the glomerular filtration rate and the new huge formula, J. M. González-Santos (Spain)
5. Topical negative pressure for the treatment of deep sternal wound infection and madiastinitis after cardiac surgery, S. Borovic (Serbia)
6. Surgical management of renal cell carcinoma with invasion of the inferior vena cava and right atrium: case report, B. Aureliu (Moldova)
7. Heart injuries - Emergency surgery and predictors for reintervention, . Batrinac ()
8. Managing Sternal Defects After Cardiovascular Surgery with Free Flaps, S. Theodosiadi (Germany)
9. Dysphagia as a coronary surgery complication, V. Vujic (Serbia)
10. Cardiac surgery in patients with liver cirrhosis: not as simple as expected due to point-by-point increase in mortality, M. Aleksic (Germany)
16:30 - 18:30CARDIAC YOUNG SURGEONS’ AWARD SESSION
Hall: Atlantic I + II
Chairman:O. Oto (Turkey)
Jury: O.Oto, Z.Sutlic, F.Doguet, M. Thielman, T. Folliguet
1. Postoperative Complications and The Degree of Patients’ Satisfaction After Radial Artery Harvesting for Coronary Artery Bypass, A. Milutinovic (Serbia)
2. Clinical and Echocardiographic Outcomeat Three Years in Patients with Functional Tricuspid Regurgitation comparing Annuloplasty with Rigid Ring, Flexible Ring and De Vega Technique, J. Hernández (Spain)
3. Early results of valve sparing aortic root reconstruction in acute Stanford type A aortic dissection, M. Wahba (Egypt)
4. Systolic Stretching ofthe Ascending Aorta as A New Method of the Assessment of Elasticity of the Aortic Wall, T. Plonek (Poland)
5. Biomechanical Analysis ofthe Ascending Aorta – A Finite Elements Study, T. Plonek (Poland)
6. Combination of Port-Access and Direct Vision in Open Heart Surgery. Initial Three Years Single Center Experience, A. Kurmalayev (Kazakhstan)
7. Innominate vein cannulation: easy but neglected technique, M. Akbulut (Turkey)
8. Comparison of frozen elephant trunk technique according different zone implantation, M. Akbulut (Turkey)
9. Aortic Cryopreserved Allograft Implantation in Reoperations for Active Prosthetic Endocarditis with Aortic Root Destruction, M. Kokoev (Russian Federation)
10. Aortic Cryopreserved Allograft Implantation in Reoperations for Active Prosthetic Endocarditis with Aortic Root Destruction, D. Sef (Croatia)
11. Algisyl-LVR™ ventriculoplasty in Patients with Dilated Cardiomyopathy - the cardiovascular surgeon's perspective, C. A. Buzila (Romania)
12. The Association Between Platelet to Lymphocyte Ratio, Red Cell Distribution Width, Mean Platelet Volume and Postoperative Atrial Fibrillation in Patients Underwent Coronary Artery Bypass Surgery Operation: Can We Predict Postoperative Atrial Fibrillation by Using These Values?, A. Özgür (Turkey)
1. Postoperative Complications and The Degree of Patients’ Satisfaction After Radial Artery Harvesting for Coronary Artery Bypass, A. Milutinovic (Serbia)
2. Clinical and Echocardiographic Outcomeat Three Years in Patients with Functional Tricuspid Regurgitation comparing Annuloplasty with Rigid Ring, Flexible Ring and De Vega Technique, J. Hernández (Spain)
3. Early results of valve sparing aortic root reconstruction in acute Stanford type A aortic dissection, M. Wahba (Egypt)
4. Systolic Stretching ofthe Ascending Aorta as A New Method of the Assessment of Elasticity of the Aortic Wall, T. Plonek (Poland)
5. Biomechanical Analysis ofthe Ascending Aorta – A Finite Elements Study, T. Plonek (Poland)
6. Combination of Port-Access and Direct Vision in Open Heart Surgery. Initial Three Years Single Center Experience, A. Kurmalayev (Kazakhstan)
7. Innominate vein cannulation: easy but neglected technique, M. Akbulut (Turkey)
8. Comparison of frozen elephant trunk technique according different zone implantation, M. Akbulut (Turkey)
9. Aortic Cryopreserved Allograft Implantation in Reoperations for Active Prosthetic Endocarditis with Aortic Root Destruction, M. Kokoev (Russian Federation)
10. Aortic Cryopreserved Allograft Implantation in Reoperations for Active Prosthetic Endocarditis with Aortic Root Destruction, D. Sef (Croatia)
11. Algisyl-LVR™ ventriculoplasty in Patients with Dilated Cardiomyopathy - the cardiovascular surgeon's perspective, C. A. Buzila (Romania)
12. The Association Between Platelet to Lymphocyte Ratio, Red Cell Distribution Width, Mean Platelet Volume and Postoperative Atrial Fibrillation in Patients Underwent Coronary Artery Bypass Surgery Operation: Can We Predict Postoperative Atrial Fibrillation by Using These Values?, A. Özgür (Turkey)
16:30 - 18:30BEST CARDIAC POSTER SESSION
Hall:Danube
Moderators: T. Gencipar (Turkey), V.G.Ruggieri (France), M.Rosic (Serbia)
Abstract presentations 3+1 min
Abstract presentations 3+1 min
1. Renal malperfusion in acute aortic dissection type A operated– early and mid outcomes, R. Geana (Romania)
2. Aortic valve sparing procedures – a single institution experience, J. Jelenc (Slovenia)
3. Triangular Plasty ofLeft Atriumfor Atriomegaly During Mitral Valve Replacement, V. Popov (Ukraine)
3. Triangular Plasty ofLeft Atriumfor Atriomegaly During Mitral Valve Replacement, V. Popov (Ukraine)
4. Single centre 7-year experience of trans-catheter valve implantation, A. Panayiotou (Great Britain)
5. Novel method for ex-vivo preservation of donor heart using blood cardioplegia and the Organ Care System, R. Kaliyev (Kazakhstan)
5. Novel method for ex-vivo preservation of donor heart using blood cardioplegia and the Organ Care System, R. Kaliyev (Kazakhstan)
6. Controversies and challenges in coronary and carotid artery occlusive disease treatment, P. Kovacevic (Serbia)
7. Septal Myectomy as a Successful Surgical Treatment for Dynamic Obstruction of Left Ventricular Outflow Tractin Hypertrophic Cardiomyopathy Without a Dedicated Team: Is It Possible?, C. G. Ciobanu (Romania)
8. Hypoxia Pre-Conditioningof Human Adipose Tissue-derived Stromal Vascular Fraction Cell Patches for Ischemic Heart Disease Treatment, G. Cerino (Switzerland)
9. Results of aortic valve repair david surgery vs. Biological bentall procedure with echocardiography follow-up after 4 year practice at our centre, A. Ljubacev (Croatia)
10. Short-term outcomes of patients undergoing aortic valve replacement after previous coronary artery bypass grafting, L. Velicki (Sebia)
11. Postoperative outcome in patients with bacterial endocarditis undergoing surgery, K. Krakulli (Albania)
12. In Situ Bentall Operation – Good Solution for Reoperative Aortic Surgery, B. Djukanovic (Serbia)
13. Case report: Simultaneous open heart and gynecological surgery, M. Lukic (Serbia)
10. Short-term outcomes of patients undergoing aortic valve replacement after previous coronary artery bypass grafting, L. Velicki (Sebia)
11. Postoperative outcome in patients with bacterial endocarditis undergoing surgery, K. Krakulli (Albania)
12. In Situ Bentall Operation – Good Solution for Reoperative Aortic Surgery, B. Djukanovic (Serbia)
13. Case report: Simultaneous open heart and gynecological surgery, M. Lukic (Serbia)
14. Natural history of aortic wall changes in adults with degenerative aortic stenosis: morphometric proofs and implications for echocardiography, S. Borovic (serbia)
15. Extracorporeal membrane oxygenation (ecmo) as a bridge to surgery in two patients with post-infarction ventricular septal defect, D. Radakovic (Germany)
16. First implantation of the heartmate III left ventricular assist device, M. Kusurin (Croatia)
16. First implantation of the heartmate III left ventricular assist device, M. Kusurin (Croatia)
17. Surgical treatment of isolated mitral valve disease complicated by massive thrombosisofleft atrium, V. Popov (Ukraine)
18. A 55 year-old female patient with the left main coronary artery originating from the pulmonary artery (ALCAPA), Ö. Berkan (Turkey)
19. Optimal therapeutic approach in aortic coarctation and associated cardiac lesions-our experience, R. Karan (Serbia)
19. Optimal therapeutic approach in aortic coarctation and associated cardiac lesions-our experience, R. Karan (Serbia)
20. Occlusion of right coronary artery after aortic valve replacement in a patient with single coronary artery, Y.Jung (Korea)
21. Is it possible to operate aortic arch without deep hypothermia?, R. Ilic (Serbia)
22. Whether stenting is the best choice for myocardial "bridges"?, O. Gogayeva (Ukraine)
23. Correction of the congenital heart malformations in adults, I. Ye. Sagatov (Kazakhstan)
24. Takotsubo cardiomyopathy after elective aortic valve replacement surgery, O. Al Razo (Spain)
25. Coronary artery rupture without pericardial effusion: a diagnostic challenge, U. Sevuk (Turkey)
26. Tubular patch prepared using recipient’s right atrial tissue; a new technique to repair short vena cava inferior, M. Balkanay (Turkey)
26. Tubular patch prepared using recipient’s right atrial tissue; a new technique to repair short vena cava inferior, M. Balkanay (Turkey)
27. Extraanatomical bypass for aortic coarctation repair via sternotomy- mid term clinical results, S. Micovic (Serbia)
28. Postoperative results in adult patients with congenital heart defects and intracardiac shunting, O. Repin (Moldova)
29. Aortic root enlargement procedures in adult patients with congenital stenosis of aortic valve, R. Ilic (Serbia)
30. Atrial septal defect closure – from minimally invasivetechnique to conventionalsurgery, O. Gokalp (Turkey)
31. Constrictive pericarditis due to sarcoidosis: a challenging diagnosis, R. A. Arévalo-Abascal (Spain)
Global
08:40 - 12:00Registrations 19:30 - 21:00Opening CeremonyBelgrade National Theatre 19.30-21h
Official protocol of Opening Ceremony:
Welcome Address of the Chairmen of the Local Organizing Committee of the 65th ESCVS Congress, Belgrade 2016
L. Davidovic, Chairman of the Local Organizing Committee of the 65th ESCVS Congress
Welcome Adress of ESCVS President
O. Oto, ESCVS President 2014-2016
Adress of Honorary Guests og the 65th ESCVS Congress
Z. Loncar, Minister of health
V. Bumbasirevic, Rector, University of Belgrade
Adress of ESCVS Secretary General
V. Treska, Escvs Secretary General
Scientific Program Committee Address
T. Ulus, Chairmen Of the Vascular and Endovascular Scientific Program Committee
M. Fabri, Chairmen of the Local Cardiac Scientific Program Committee
I. Koncar, Chairmen of the Local VAscular Scientific Program Committee
Presentation form the Host of the 66th ESCVS Congress
A. Giannoukas, (Thesalloniki, Greece)
CHairmen of the Local Organizing Committee of the 66th ESCVS Congress
20 min intermezzo - Movie Presentation
Ballet
"Who is singing out there", 67 minutes
Vascular program
08:00 - 09:30Abstract session VIII: ENDOVASCULAR PROCEDURES Hall: Adriatic
Moderators:M.Gasparini (Slovenia), S. Cvetkovic (Serbia)
Key Note Lecture: Endovascular procedures in Romania, I.Droc (Romania) 9 minutes
1. Safety and efficacy of ultra-high-dose, short-term thrombolysis with rt-PA for acute lower limb ischemia, R. A. Samad (Poland)
2. Endovascular management of blunt axillo-subclavian arterial injuries as the first – choice treatment, G. Kouvelos (Greece)
3. Mid term results after drug eluting stenting of superficial femoral artery in Critical Limb Ischemia patients. An italian multicentre Registry, G. Galzerano (Italy)
4. The use of an innovative balloon catheter (Chocolate) in femoro-popliteal occlusive disease, W. Mansour (Italy)
5. Real world experience in using the covered heparin-bonded stents for infra-inguinal occlusive disease, S. Vimalesvaran (United Kingdom)
6. Remote Hybrid Iliac Endo-Endarterectomy: Early Results, S. Bonvivi (Italy)
7. Long-term outcome following stent reconstruction of totally occluded infrarenal aortic bifurcation, A. Siani (Italy)
8. Is There Outcome Differences between Total and Non-Total Occlusion in Patients undergoing Superficial Femoral Artery Intervention?, J. Ahn (Korea)
9. The use og bioactive stent HeliFlex in patients with atherosclerotics lesions ofsuperficial femoral artery: First Experience, M. Generalov (Russian Federation)
08:00 - 09:30Abstract session IX: RESEARCH Hall: Danube
Moderators:I. Lovricevic (Croatia).;P. Matic(Serbia)
Key Note Lecture:Update on long-term behavior mechanical of new generations of endoprostheses. N. Chakfe (France) 9 minutes
1. Role of calcifying nanoparticle in the development of hyperplasia and vascular calcification in an animal model, N. Cenizo-Revuelta (Spain)
2. Functionalizing small diameter vascular grafts with gelatin, B. Aliakbarian (Italy)
3. Inflammation as Carotid Restenosis Predictor Following Eversion Endarterectomy, S Tanaskovic (Serbia)
4. Prognosticvalue of neutrophil-to-lymphocyte ratio in patients undergoing endovenous ablation therapy for venous insufficency, A. B. Budak (Turkey)
5. Carotid bifurcation geometry is assosiated with common carotid intima- media thickness, G. Petrocheilou (Greece)
6. Cerebral oxidative damage and the use of shunt during carotid endarterectomy, M. Dragas (Serbia)
7. Biomechanical properties of isolated rabbit carotid artery in experimental atherosclerosis, V. Jokovic (Serbia)
8. Hemodynamic variation on renal arteries in custom- made and pivot branch fenestrated grafting with different orientations of renal stents, J. Ou (Hong Kong, China)
9. The impact of smoking status on the endothelial function and left ventricle systolic function in coronary artery disease, Jae BinSeo (South Korea)
08:00 - 09:30VASCULAR CINEMA II Hall: Atlantic I
Moderators: N.Jakovljevic (Serbia), G.Sokurenko (RF)
Video presentation of procedures for particular pathology with authors’ commentary
1. Standardized procedure in branched Stentgrafts for TAAA, Pi.Kasprzak,(Germany)
2. Endovascular sealing of the aneurysm using the Nelix device, M.Reijnen, (Netherland)
3.Transcervical carotid stenting - Silk Road Medical, S.McDonald, (UK)
4. Simultaneous carotid and vertebral revascularization, M. Shatakhyan (Armenia)
08:00 - 09:30Abstract session: CARDIOVASCULAR ANESTHESIA & CRITICAL CARE
Hall: Mediterranean
Moderators: M. Jovic (Serbia), G. Voga (Slovenia)
1. Cervical plexus block for carotid endarterectomy: intraoperative hemodynamic stability in patients with different degree of cardiovascular disease, K. Stevanovic (Serbia)
2. Anesthetic challenge in infant presenting with Bland-White-Garland syndrome, B. Mojsic (Serbia)
3. Central venous-to-arterial carbon dioxide difference in cardiac surgical patients, D. Unic Stojanovic (Serbia)
4. Cardio – organoprotection, M. Jovic (Serbia)
5. Implications of acute kidney injury after cardiac surgery: what we should know, M. Filipovic (Serbia)
6. General versus regional anaesthesia for carotid endarterectomy, D. Unic Stojanovic (Serbia)
7. Rotation thromboelastometry in goal-directed treatment of bleeding-case reports, T. Kocica (Serbia)
8. Influence of open surgical and endovascular abdominal aortic aneurysm repair on clot quality assessed by ROTEM® test, M. Sarac (Serbia)
9. Predictors of anesthesia outcome after general noncardiac surgical procedures in neonates with congenital heart disease, M. Stevic (Serbia)
08:00 - 11:00Seminar in Thrombosis and Antithrombotic Therapy Hall: Pacific
Course director: M. Matsagkas (Greece)
Moderators: M. Matsagkas (Greece), I. Banzic (Serbia)
Part A Arterial disease
08.00 – 08.15 Antithrombotic treatment in peripheral arterial interventions G. Kouvelos (Greece)
08.16 – 08.30 Antithrombotic treatment in carotid interventions I. Banzic(Serbia)
08.31 – 08.45 Optimal antithrombotic treatment during cardiac surgery S.Putnik (Serbia)
08.46 – 09.00 Antithrombotic treatment during combined cardiac surgery and carotid intervention M. Matsagkas (Greece)
09.01 – 09.10 Discussion
Part B Venous Thromboembolism
09.11 – 09.20 Pathophysiology of heamostasis and thrombosis N. Roussas (Greece)
09.21 - 09.35 The recently published ESC guidelines for pulmonary embolism - New treatment strategies Vassil Chervenkof (Bulgaria)
09.36 - 09.50 NOACs in the treatment of VTE. Clinical implications M. Matsagkas (Greece)
09.51 – 10.00 Discussion
Part C Peri-operative antithrombotic management
10.01 – 10.40 Managing patients under anti-thombotic therapy to undergo non-cardiac surgery E.Arnaoutoglou (Greece)
10.41 – 10.50. Discussion
Satellite presentation
10.51 - 11.00 HEMOFARM
Acetylsalicylic acid in reducing cardiovascular events D. Kostic (Serbia)
09:00 - 10:45JOINT SESSION WITH ESVS Hall: Atlantic II
Moderators: O.Oto (Turkey), A. Javien (Poland), S.Debus (Germany), L. Davidovic (Serbia)
1. AAA risk of rupture, is it possible to predict, D. Palombo (Italy), ESCVS
2. Comparative analysis for open and endovascular repair of thoraco-abdominal aortic aneurysms, Andrea Kahlberg (Italy), ESVS
3. Long term survival after TEVAR, T. Ulus (Turkey), ESCVS
4. FEVAR as first line treatment for pararenal AAA, Thanos Katsargyris (Germany), ESVS
5. Mesenteric ischaemia after AAA repair, V. Treska (Czech Republic), ESCVS
6. FEVAR and BrEVAR for treatment of Aortic Arch Aneurysms, Sebastian Debus (Germany), ESVS
09:45 - 10:45Cardiovascular Cinema Video presentation of procedures for particular pathology with moderators
11:00 - 13:00VASCULAR SYMPOSIUM: THORACOABDOMINAL AORTA Thoracoabdominal aorta
Hall: Atlantic I+II
Moderators: V.Riambau (Spain), P.Kasprzak, (Germany); L. Davidovic (Serbia)
1. Extra anatomic bypass for congenital and acquired disorders of the thoracic aorta: indications, technique, results.- V. Arakelyan (Russia)
2. Timing of intervention in patients with type B uncomplicated dissection - J.Brunkwall, (Germany)
3. Dose optimized imaging protocols for complex endovascular procedures –E.Verhoeven, (Germany)
4. Open conversions after TEVAR- A. Kahlberg (Italy)
5. Patency of branches after FEVAR and BEVAR- P.Kasprzak(Germany)
6. Surgical treatment options for chronic visceral ischemia- C. Dzinich(Hungary)
7. Strategies to reduce paraplegia after endovascular TAAA repair– V. Riambau (Spain)
8. Different mechanisms of spinal cord ischemia after TAAA repair-N.Ilic(Serbia)
13:00 - 14:00Lunch Symposium: VAC THERAPY IN VASCULAR SURGERY Hall: Aegean + Baltic
Detailed program inserted in the congress bag
14:00 - 16:00VASCULAR SYMPOSIUM: VASCULAR BIOLOGY AND BIOMEDICAL ENGINEERING Hall: Atlantic I + II
Moderators: D. Palombo (Italy), T. Ulus (Turkey),N. Filipovic(Serbia)
1. Genetic background of paragangliomas - M.Menegolo (Italy)
2. Biodegradable and engineered vascular prosthesis: a surgeon’s view- D. Palombo(Italy)
3. Oxidative stress parameters after carotid surgery – M.Dragas (Serbia)
4. Biodegradable vascular prosthesis: the role of Chemical Engineer.- P. Perego (Italy)
5. Biological process in computer simulation, how far can we go? - N.Filipovic (Serbia)
6. The role of intraluminal thrombus in development of rupture of AAA – N.Kontopodis (Greece)
7. Displacement forces in thoracic aorta - D. Krsmanovich (USA)
8. Biomarkers of endoleak – results from BIOLEAK trial – I.Koncar (Serbia)
9. PET/CT in the abdominal aneurysm:correlation with the cellular and molecularalterations in the aneurysmal wall. N. Sacalihasan (Belgium)
14:00 - 15:00Lunch Sympsium II: Computational Surgery Hall: Atlantic I+II
Moderators: N. Filipovic (Serbia), M. Garbey (USA)
1. Challenges in vascular adaptation: from observation to control, M. Garbey (USA)
2. Modeling Coronary Artery Disease for decision support in interventional treatment, T. Exarchos (Greece)
3. Modeling if the AAA for surgical intervention, N. Filipovic (Serbia)
14:00 - 15:00JOINT SESSION WITH SERBIAN SOCIETY FOR HEART FAILURE Hall: Baltic & Aegean
Diabetes and heartfailure: pathophysiology, clinical presentation and treatment Moderators: S. Dodic (Serbia), S. Pavlovic (Serbia)
1. Diabetes, heart failure and advanced glycation end products: Clinicaly relevant hidden links? M. Mamas (UK)
2. Dysglicaemia and heart failure phenotypes: clinical presentation and therapeutic implications P. Seferovic (Serbia)
3. Acute coronary syndrome in type 2 diabetes: Optimal clinical and treatment strategies A. Oto (Turkey)
4. Acute heart failure and diabetes: prognostic and therapeutic aspects A. Ristic (Serbia)
5. Antiglycemic drugs in heart failure: friends or foe? Michael Theodorakis (UK)
16:30 - 18:00VASCULAR SYMPOSIUM: PERIPHERAL OCCLUSIVE DISEASE Hall Adriatic and Mediterranean
Moderators:G. Marccuci (Italy), A. Jawien (Poland),N. Ilijevski(Serbia)
1. What is the optimal treatment for SFA long occlusion? – A. Jawien (Poland)
2. Endoluminal robotic navigation for treatment of aortoiliac occlusive disease-N. Chakfe (France)
3. Cost effective treatment of PAOD – F.Grego (Italy)
4. Statin therapy in PAD.-R. Bulbulia (UK)
5. Drug eluting stents in below the knee lesions- R.Fernandes (Portugal)
6. Covered stents in aorto-iliac occlusive disease, when and why? – G.Marccuci (Italy)
7. Angiosome concept – is it working? – F. Vermassen (Belgium)
8. In stent SFA and popliteal restenosis: best management: current data and next future - E. Ducasse (France)
Cardiac program
08:00 - 09:30Abstract session VI: ATRIAL FIBRILLATION
Hall: Baltic
Moderators: B.Gersak ( Slovenia), A.Redzek (Serbia)
Key Note Lecture: B.Gersak (Slovenia) What to expect from the future treatment of persistent AF: Breakthrough or Perpetuum Mobile?
9 minutes
1. Surgical Treatment of Atrial Fibrillation (STAF) as a Concominant Procedure - 10 Years Experience, L. Boyadzhiev (Bulgaria)
2. Late Results of Surgical Radiofrequency Ablation of Atrial Fibrillation, M. Fabri (Serbia)
3. Implantable cardioverter defibrillators in prevention of sudden cardiac death in ischemic HEART disease and coronary artery bypass graft surgery, R. Karan (Serbia)
4. Post Coronary Bypass Surgery and New-onset of Atrial Fibrillation – Sarajevo's Cardiac Surgery Experience, S. Straus (Bosnia and Herzegovina)
5. The relationship between postpericardiotomy syndrome and atrial fibrillation following cardiac surgery, U. Sevuk (Turkey)
6. Left Mini Thoracotomy as an approach for stimulation of the left ventricle in cardiac resinhronisation therapy, N. Aleksic (Serbia)
08:00 - 09:30Abstract session VII: CORONARY SURGERY I Hall: Aegean
Moderators: M.Thielman (Germany), S. Micovic (Serbia)
Key Note Lecture: Coronary surgery in 2016, M. Thielman (Germany) 9 minutes
1. Effect of coronary artery bypass grafting in ejection fraction in patients with low preoperative left ventricular ejection fraction, F. López Valdiviezo (Spain)
2. Influence of postoperative anemia on functional capacity recovery in patients undergoing coronary artery bypass grafting, Hsin Yi Huang (Taiwan)
3. The use of two internal thoracic arteries as the gold standard of the coronary bypass surgery, A. Cherkes (Russian Federation)
4. Bilateral Sceletonized IMAs: “in situ” Grafts forDifferent Coronary Territories, Z. Jonjev (Serbia)
5. Acute Kidney Injury (AKI) Following Elective Coronary Artery Bypass Graft Surgery: Preoperative Risk Factors and Outcomes One Year On, A. Isted (United Kingdom)
6. Synchronous CEA and CABG vs. solely CABG: still existing dilemma, V. Jovicic (Serbia)
7. Patients’ operation results repaired with a patch due to left ventricle aneurysm, E. Aliyev (Azerbaijan)
8. Unsuccesful surgical correction ofa severely ectatic circumflex artery fistula to coronary sinus, R. Blazenkovic (Croatia)
9. Differentiated approach to choice the methodic of coronary artery bypass grafting. Experience in 3454 patients, P. Myaluk (Russian Federation)
10. Functional evaluation of the coronary ischemia using coronary flow velocity reserve after coronary artery bypass surgery in left ventricular hypertrophy, K. Honda (Japan)
08:00 - 09:30Abstract session: CARDIOVASCULAR ANESTHESIA & CRITICAL CARE
Hall: Mediterranean
Moderators: M. Jovic (Serbia), G. Voga (Slovenia)
1. Cervical plexus block for carotid endarterectomy: intraoperative hemodynamic stability in patients with different degree of cardiovascular disease, K. Stevanovic (Serbia)
2. Anesthetic challenge in infant presenting with Bland-White-Garland syndrome, B. Mojsic (Serbia)
3. Central venous-to-arterial carbon dioxide difference in cardiac surgical patients, D. Unic Stojanovic (Serbia)
4. Cardio – organoprotection, M. Jovic (Serbia)
5. Implications of acute kidney injury after cardiac surgery: what we should know, M. Filipovic (Serbia)
6. General versus regional anaesthesia for carotid endarterectomy, D. Unic Stojanovic (Serbia)
7. Rotation thromboelastometry in goal-directed treatment of bleeding-case reports, T. Kocica (Serbia)
8. Influence of open surgical and endovascular abdominal aortic aneurysm repair on clot quality assessed by ROTEM® test, M. Sarac (Serbia)
9. Predictors of anesthesia outcome after general noncardiac surgical procedures in neonates with congenital heart disease, M. Stevic (Serbia)
08:00 - 11:00Seminar in Thrombosis and Antithrombotic Therapy Hall: Pacific
Course director: M. Matsagkas (Greece)
Moderators: M. Matsagkas (Greece), I. Banzic (Serbia)
Part A Arterial disease
08.00 – 08.15 Antithrombotic treatment in peripheral arterial interventions G. Kouvelos (Greece)
08.16 – 08.30 Antithrombotic treatment in carotid interventions I. Banzic(Serbia)
08.31 – 08.45 Optimal antithrombotic treatment during cardiac surgery S.Putnik (Serbia)
08.46 – 09.00 Antithrombotic treatment during combined cardiac surgery and carotid intervention M. Matsagkas (Greece)
09.01 – 09.10 Discussion
Part B Venous Thromboembolism
09.11 – 09.20 Pathophysiology of heamostasis and thrombosis N. Roussas (Greece)
09.21 - 09.35 The recently published ESC guidelines for pulmonary embolism - New treatment strategies Vassil Chervenkof (Bulgaria)
09.36 - 09.50 NOACs in the treatment of VTE. Clinical implications M. Matsagkas (Greece)
09.51 – 10.00 Discussion
Part C Peri-operative antithrombotic management
10.01 – 10.40 Managing patients under anti-thombotic therapy to undergo non-cardiac surgery E.Arnaoutoglou (Greece)
10.41 – 10.50. Discussion
Satellite presentation
10.51 - 11.00 HEMOFARM
Acetylsalicylic acid in reducing cardiovascular events D. Kostic (Serbia)
09:45 - 10:45CARDIAC CINEMA Hall: Baltic
Video presentation of procedures for particular pathology with authors’ commentary
Moderator: F.Santini (Italy) , S. Schueler (United Kingdom), S.Susak (Serbia)
Transcarotid TAVI, T. Folliguet (France)
Modified Ozaki procedure - revival of forgotten technique, L. Himpel (Germany)
Minimally Invasive MVR with Cryo Ablation and LAA Closure T. Weimar (Germany)
11:00 - 13:00 CARDIAC SYMPOSIUM: COMPLEX CORONARY SURGERY, IS IT OUR FUTURE? Hall: Aegean + Baltic
voting system; Session Learning Objective(s):
Discuss the practical management of complex coronary disease in 2015 - interactive session
Moderators: O.Oto (Turkey), Z.Sutlic (Croatia), S.Kacar (Serbia)
1. Arterial grafts for coronary artery bypass surgery: biological characteristics, spasm, and management, Guo-Wei He (China)
2. Redo coronary surgery - case discussion, E.Demirsoy (Turkey)
3. Concomitant rapid deployment valve and coronary surgery- case discussion, T.Klokocovnik (Slovenia)
4. Coronary hybrid treatment options - case discussion, Mi. Zembala (Poland)
5. Mitral dystrophy in octogenarians with concomitant coronary surgery, case discussion, T.Folliguet (France)
13:00 - 14:00Lunch symposium I TAVI/TMVI
Hall: Mediteraneo + Adriatic
Moderators: M.Thielmann (Germany), V.Bapat (UK), LJ. Mangovski (Serbia)
1. Transcathetermitral valve replacement - where are we currently? G. Lutter (Germany)
2. TF in the hands of a surgeon, Mi. Zembala (Poland)
3. Expanding the limits of TAVI, M. Thielmann (Germany)
4. Development of TAVI program in the Balkan region D. Unic (Croatia)
13:00 - 14:00Atricure Lunch Symposium Hall: Pacific
“Current status and latest developments on Sole/Hybrid AF Ablation”
Moderator: Timo Weimar, MD (Germany)
1. “Surgical Options in Sole- and Hybrid Therapy Ablation Approaches” - Timo Weimar, MD - Germany
2. “Single Stage Hybrid AF Ablation using the Converge Approach” - Michael Zembala, MD - Poland
14:00 - 16:00CARDIAC SYMPOSIUM: UPDATE IN ATRIAL FIBRILLATION SURGERY Hall: Pacific
Moderators: Mi.Zembala (Poland), T.Folliguet (France), A.Redzek (Serbia)
1. Why should we treat AF? (Maze IV procedure), T.Weimar (Germany)
2. Concomitant AF ablation, F.Rega (Belgium)
3. LAA management, S.Salsberg (Switzerald)
4. Sole therapy versus hybrid approach, P Suwalski (Poland)
14:00 - 16:00JOINT SESSION WITH SERBIAN SOCIETY FOR HEART FAILURE Hall: Baltic & Aegean
Diabetes and heartfailure: pathophysiology, clinical presentation and treatment Moderators: S. Dodic (Serbia), S. Pavlovic (Serbia)
1. Diabetes, heart failure and advanced glycation end products: Clinicaly relevant hidden links? M. Mamas (UK)
2. Dysglicaemia and heart failure phenotypes: clinical presentation and therapeutic implications P. Seferovic (Serbia)
3. Acute coronary syndrome in type 2 diabetes: Optimal clinical and treatment strategies A. Oto (Turkey)
4. Acute heart failure and diabetes: prognostic and therapeutic aspects A. Ristic (Serbia)
5. Antiglycemic drugs in heart failure: friends or foe? Michael Theodorakis (UK)
16:30 - 18:00CARDIAC SYMPOSIUM: SUTURELESS AORTIC VALVE Hall: Pacific
Moderators:O.Oto (Turkey), F.Doguet (France), S.Putnik (Serbia)
1. Rationale and design of the PERSIST AVR Trial, T Fischlein (Germany)
2. Hemodynamics assessment in sutureless valves, T.Hanke (Germany)
3. Reimbursement and health economic evidence for the sutureless and rapid deployment valves, T Fischlein (Germany)
4. Valve in valve in sutureless and rapid deployment valves, V. Bapat (UK)
5. New developments in aortic valve surgery, T.Folliguet (France)
6. Incidence of perioperative rhythm disorders and pacemaker dependency in sutureless compared to stented bioprosthetic heart valves, P.Oberwalder (Austria)
Vascular program
08:30 - 10:30SYMPOSIUM: CARDIOVASCULAR ANESTHESIA & CRITICAL CARE Hall: Pacific
Chair: M. Jovic (Serbia), G.Landoni (Italy)
1. Monitored Anesthesia Care for EVAR: Less is more E. Arnaoutoglou (Greece)
2. Levosimendan for organ protection in critically ill patients. G. Landoni (Italy)
3. Hemodynamic monitoring in critically ill patients: how to select the right method? G. Voga (Slovenia)
4. Anesthetics and cardioprotection - What are our expectations in future?, M.Jovic (Serbia)
5. Extracorporeal membrane oxygenation: experience in primary graft dysfunction after heart transplantation, N. Bradic (Serbia)
09:00 - 10:30Abstract session X: HEMODIALYSIS Hall: Danube
Moderators: M.Petrunic (Croatia), S. Tanaskovic(Serbia)
Key Note Debate:
In elderly patients liberal use of grafts is recommended, S. Baktiroglu (Turkey) 7 minutes
Always autologous AVF fistulas in elderly patients M.Lazarides (Greece) 7 minutes
Disscussion voting
1. Enhanced maturation and prevention of juxtaanastomotic stenosis of arteriovenous fistula, V. Milacic (Serbia)
2. The use of vascular dilators in vascular access procedures for haemodialysis, B. Fila (Croatia)
3. Early AV Fistula Revisions in Chronic Hemodialysis Patients, S.Göksel (Turkey)
4. Dialysis access infection: Impact of prosthetic material on clinical presentation, surgical management and outcomes, M. Z. Ghariani (Tunisia)
5. Results of the surgical management of dialysis access stenoses, M. Z. Ghariani (Tunisia)
6. Rational choice of permanent vascular approach for hemodialysis, I. Kuzmanovic (Serbia)
2. The use of vascular dilators in vascular access procedures for haemodialysis, B. Fila (Croatia)
3. Early AV Fistula Revisions in Chronic Hemodialysis Patients, S.Göksel (Turkey)
4. Dialysis access infection: Impact of prosthetic material on clinical presentation, surgical management and outcomes, M. Z. Ghariani (Tunisia)
5. Results of the surgical management of dialysis access stenoses, M. Z. Ghariani (Tunisia)
6. Rational choice of permanent vascular approach for hemodialysis, I. Kuzmanovic (Serbia)
09:00 - 10:30Abstract session XI: EVAR Hall: Adriatic
Moderators: P. Kasprzak (Germany), I. Banzic (Serbia)
Key Note Lecture: Infected endografts: is it a clinical problem? (FDG distribution patterns in PET scanning to improve accuracy of diagnosing vascular prosthetic graft infection, C. Zeebrechts (Netherlands)
Key Note Lecture: Radical management of endograft infection. F. Speziale (Italy)
Key Note Lecture: Radical management of endograft infection. F. Speziale (Italy)
1. Evar complications related to high velocity traumas: mith or reality?, G. Galzerano (Italy)
2. 3D Ultrasound for EVAR surveillance – goal or gimmick?, H. Apfelbeck (Germany)
3. Aneurysmal Sac Glue Embolization in Emergency Endovascular Aneurysm Repair for Ruptured Abdominal Aortic Aneurysm, R. Hosino (Japan)
4. Long-term results for EVAR in women, P. Konstantiniuk (Austria)
5. Pre-operative morphological features predict late distal type I endoleaks, E. Gallitto (Italy)
6. New single-sided access evar device: the horizon ce pivotal study– short-term results, I. Banzic (Serbia)
7. Gender specific analysis of a low-profile EVAR device, T. Nolte (Germany)
8. Hybrid theatre with image fusion for endovascular aortic aneurysm repair, T. Somacescu (United Kingdom)
9. Off-the-shelf stent grafts implantations as the solution for treatment of some aorta and iliac artery aneurysms, M. Nowacki (Poland)
2. 3D Ultrasound for EVAR surveillance – goal or gimmick?, H. Apfelbeck (Germany)
3. Aneurysmal Sac Glue Embolization in Emergency Endovascular Aneurysm Repair for Ruptured Abdominal Aortic Aneurysm, R. Hosino (Japan)
4. Long-term results for EVAR in women, P. Konstantiniuk (Austria)
5. Pre-operative morphological features predict late distal type I endoleaks, E. Gallitto (Italy)
6. New single-sided access evar device: the horizon ce pivotal study– short-term results, I. Banzic (Serbia)
7. Gender specific analysis of a low-profile EVAR device, T. Nolte (Germany)
8. Hybrid theatre with image fusion for endovascular aortic aneurysm repair, T. Somacescu (United Kingdom)
9. Off-the-shelf stent grafts implantations as the solution for treatment of some aorta and iliac artery aneurysms, M. Nowacki (Poland)
09:00 - 10:30Abstract session XII: AAA Hall: Mediteranean
Moderators: Z. Rancic (Switzerland);M.Markovic (Serbia)
Key Note Lecture: Different rates of untreated patients with RAAA in the literature. M.Markovic (Serbia)
1. New scale in predicting mortality ruptured abdominal aortic aneurysms, E. M. San Norberto (Spain)
2. A systematic review on management of concomitant abdominal aortic aneurysm and colorectal cancer, G. KOuvelos (Greece)
3. Are evar studies fair to open surgery?, I. Lovricevic (Croatia)
4. Effects of atmospheric pressure dynamics and biometeorological phases on abdominal aortic aneurysm rupture onset, D. Opacic (Netherlands)
5. Intraspinal pressure changes after aortic aneurysm repair mapped by quantification of the optic sheath diameter, S. LUnz (Germany)
6. Open repair of aaa in a high volume centre, P. Mutavdzic (Serbia)
7. Open repair of ruptured abdominal aortic aneurysm in modern era: a twenty years experience of a high-volume centre, I. Tomic (Serbia)
8. Analysis of renal function after thoracoabdominal aortic aneurysm repair with branched evar, B. Cucuruz (Germany)
9. Aorto-uni-iliac stent-grafting without synchronous femoro-femoral bypass for the endovascular repair of abdominal aortic aneurysms in patients with contralateral iliac occlusion, K. Parazoglou (Greece)
2. A systematic review on management of concomitant abdominal aortic aneurysm and colorectal cancer, G. KOuvelos (Greece)
3. Are evar studies fair to open surgery?, I. Lovricevic (Croatia)
4. Effects of atmospheric pressure dynamics and biometeorological phases on abdominal aortic aneurysm rupture onset, D. Opacic (Netherlands)
5. Intraspinal pressure changes after aortic aneurysm repair mapped by quantification of the optic sheath diameter, S. LUnz (Germany)
6. Open repair of aaa in a high volume centre, P. Mutavdzic (Serbia)
7. Open repair of ruptured abdominal aortic aneurysm in modern era: a twenty years experience of a high-volume centre, I. Tomic (Serbia)
8. Analysis of renal function after thoracoabdominal aortic aneurysm repair with branched evar, B. Cucuruz (Germany)
9. Aorto-uni-iliac stent-grafting without synchronous femoro-femoral bypass for the endovascular repair of abdominal aortic aneurysms in patients with contralateral iliac occlusion, K. Parazoglou (Greece)
09:00 - 10:30Cardiovascular Resident Forum Hall: Aegan
Moderators:M. Planinc (Croatia), N.Kontopodis (Greece), M.Sladojevic (Serbia)
1. What is the Optimal Mode of Mechanical Support in Transplanted Patient with Acute Graft Failure?, M. Monteagudo Vela, MD (Spain)
2. How to Handle the Big MAC: Pitfalls and Safeguards During Mitral Valve Replacement,C. Ciobanu, MD (Romania)
3. Performing Coronary Surgery in 21st Century - Should We Do More Arterial Grafts? P. Vukovic, (Serbia)
4. Current knowledge on EndoVascular Aneurysm Sealing (EVAS) with the Nellix device, M. Sladojevic, MD (Serbia)
5. Advancements in ArterioVenous access creation in complicated patients, C.Maturi (Italy)
6. Strategies to preserve internal iliac artery during Endovascular Aneurysm Repair (EVAR), K. Spanos, (Greece)
10:15 - 13:30VASCULAR SYPMOSIUM: AAA Hall: Pacific
Moderators:V. Treska (Czech Republic),V. Riambau (Spain), D. Kostic(Serbia)
Lectures: 12+3min
1. Follow up after EVAR in 2016 – J. Powel (UK)
2. Non-radical Management of Endograft Infection- M.Malina (Sweden)
3. Giant abdominal aortic aneurysm – V. Treska (Czech Republic)
4. Reduction of incisional hernia after open AAA repair – results from PRINCIPLES trial – F.Muysums (Belgium)
5. Saving inferior mesenteric artery with chimney graft – is it necessary and when? – Z.Rancic (Switzerland)
6. State of the art in aortic robotic surgery- P. Stadler(Czech Republic)
7. Open surgery for Juxtarenal aortic aneurysms – D. Palombo (Italy)
8. Quantitative histopathology of abdominal aortic aneurysms in human and in porcine models Z.Tonar (Czech Republic)
Debate:If I had asymptomatic AAA at the age of 60.
I would have chosen open surgery – L.Davidovic (Serbia)-7 min
I would have chosen EVAR – A.Stella (Italy)-7min
VOTING
VOTING
Cardiac program
08:30 - 10:30SYMPOSIUM: CARDIOVASCULAR ANESTHESIA & CRITICAL CARE Hall: Pacific
Chair: M. Jovic (Serbia), G.Landoni (Italy)
1. Monitored Anesthesia Care for EVAR: Less is more E. Arnaoutoglou (Greece)
2. Levosimendan for organ protection in critically ill patients. G. Landoni (Italy)
3. Hemodynamic monitoring in critically ill patients: how to select the right method? G. Voga (Slovenia)
4. Anesthetics and cardioprotection - What are our expectations in future?, M.Jovic (Serbia)
5. Extracorporeal membrane oxygenation: experience in primary graft dysfunction after heart transplantation, N. Bradic (Serbia)
09:00 - 11:00Abstract session VIII: CONGENITAL HEART DISEASE
Hall: Atlantic I
Moderators: O.Oto (Turkey), M.Stajevic (Serbia)
Key Note Lecture: Challenges of leading a paediatric cardiac surgery program in Serbia, M. Stajevic (Serbia)
1. Rehabilitation of hypoplastic pulmonary arteries in pulmonary atresia with ventricular septal defect: Systemic to pulmonary atrery shunt or palliative right ventricular and pulmonary artery connection?, Q. Chen (China)
2. Tricuspid valve surgery after previous radical correction of “blue” congenital heart defects, M. Saidov (Russian Federation)
3. Fontan operation with simultaneous atrioventricular valve replacement: institutional experience, D. Kovalev (Russian Federation)
4. Late reoperations after arterial switch operation for complex congenital heart disease correction, T. Danilov (Russian Federation)
5. Results of surgical treatment for neonatal aortic coarctation, V. Milovanovic (Serbia)
6. Tricuspid valve repair after previous radical correction of septal congenital heart defects, M. Saidov (Russian Federation)
7. Surgical outcome in complex double outlet right ventricle with complete atrioventricular canal defect: 15 years of experience from a single center, S. Zhang (China)
8. Valve replacement in the pediatric population – our experience, M. Stajevic (Serbia)
9. Outcomes following surgical ligation of patent ductus arteriosus in premature infants, V. Milovanovic (Serbia)
10. Comparative results of aortic valve replacement with and without Manouguian technic in adolescents with «normal» aortic annulus, V. Mataev (Russian Federation)
11. Treatment of pediatric patients with vascular anomalies causing airway obstruction, I. Sehic (Serbia)
12. Early surgery to the patients diagnosed with patent ductus arterious, E. Ege (Turkey)
13. Critical paediatric aortic stenosis with depressed left ventricular function: hybrid balloon valvuloplasty through the ascending aorta via sternotomy, K. Ma (China)
2. Tricuspid valve surgery after previous radical correction of “blue” congenital heart defects, M. Saidov (Russian Federation)
3. Fontan operation with simultaneous atrioventricular valve replacement: institutional experience, D. Kovalev (Russian Federation)
4. Late reoperations after arterial switch operation for complex congenital heart disease correction, T. Danilov (Russian Federation)
5. Results of surgical treatment for neonatal aortic coarctation, V. Milovanovic (Serbia)
6. Tricuspid valve repair after previous radical correction of septal congenital heart defects, M. Saidov (Russian Federation)
7. Surgical outcome in complex double outlet right ventricle with complete atrioventricular canal defect: 15 years of experience from a single center, S. Zhang (China)
8. Valve replacement in the pediatric population – our experience, M. Stajevic (Serbia)
9. Outcomes following surgical ligation of patent ductus arteriosus in premature infants, V. Milovanovic (Serbia)
10. Comparative results of aortic valve replacement with and without Manouguian technic in adolescents with «normal» aortic annulus, V. Mataev (Russian Federation)
11. Treatment of pediatric patients with vascular anomalies causing airway obstruction, I. Sehic (Serbia)
12. Early surgery to the patients diagnosed with patent ductus arterious, E. Ege (Turkey)
13. Critical paediatric aortic stenosis with depressed left ventricular function: hybrid balloon valvuloplasty through the ascending aorta via sternotomy, K. Ma (China)
09:00 - 10:30Abstract session IX: AORTIC SURGERY Hall: Atlantic II
Moderators: K. Tsagakis (Germany), M.Kocica (Serbia)
Key Note Lecture: Frozen Elephant Trunk in Acute Type a Dissection – Indications and Limitations K. Tsagakis (Germany)
1. Embolisation of the Atrial Septal Defects occlusion device and late removing from abdominal aorta, F. Cingoz (Turkey)
2. Comparison of left venticular apex versus other arterial cannulation sites for the operative management of acute type A aortic dissection, P. Vukovic (Serbia)
3. Valve Sparing Aortic Root Surgery Via Aortic Root Remodeling with External Root Annuloplasty: Preliminary Results In A Single Institution, N. C. Villamucho (Philippines)
4. Associated Djumbodis Aortic System Versus Conventional Surgery in Type a Dissection, C. Thierry (FRance)
5. 5 Years (2011 – 2015) Results of Type A Dissecting Aortic Aneurysms Surgical Treatment, V.I. Kravchenko (Ukraine)
6. The Safety of Intermittent Deep Hypothermic Circulatory Arrest in Low-Volume Center, K. Mershin (Russian Federation)
7. Ascending aortic repair with supra-aortic bypass for acute type A aortic dissection, H. Kitahara (Japan)
8. Impact of Mesenteric Ischemia in Patients with TypeA Acute Aortic Dissection, G.R. Carmen (Romania)
9. Frozen elephant trunk in chronic aortic disease: what device for which patient?, V. G. Ruggieri (France)
2. Comparison of left venticular apex versus other arterial cannulation sites for the operative management of acute type A aortic dissection, P. Vukovic (Serbia)
3. Valve Sparing Aortic Root Surgery Via Aortic Root Remodeling with External Root Annuloplasty: Preliminary Results In A Single Institution, N. C. Villamucho (Philippines)
4. Associated Djumbodis Aortic System Versus Conventional Surgery in Type a Dissection, C. Thierry (FRance)
5. 5 Years (2011 – 2015) Results of Type A Dissecting Aortic Aneurysms Surgical Treatment, V.I. Kravchenko (Ukraine)
6. The Safety of Intermittent Deep Hypothermic Circulatory Arrest in Low-Volume Center, K. Mershin (Russian Federation)
7. Ascending aortic repair with supra-aortic bypass for acute type A aortic dissection, H. Kitahara (Japan)
8. Impact of Mesenteric Ischemia in Patients with TypeA Acute Aortic Dissection, G.R. Carmen (Romania)
9. Frozen elephant trunk in chronic aortic disease: what device for which patient?, V. G. Ruggieri (France)
09:00 - 10:30Abstract session X: CORONARY SURGERY II Hall: Baltic
Moderators: F.Santini (Italy), S.Kacar (Serbia)
Key Note Lecture: Targeting the best treatment strategy: Addition of Frailty and Disability to Cardiac Surgery Risk Scores Identifies Elderly Patients at High Risk of Mortality or Major Morbidity, F.Santini (Italy) 9 minutes
1. CABG / PCI ratioin young adults (≤ 35-40 years of age)with coronary artery disease (CAD), F. Abdullayev (Azerbaijan)
2. Outcomes of On-pump Beating Heart versus Traditional On-Pump Coronary Artery By-Pass Grafting Surgey in end-stage renal disease patients, Ö. F. Doğan (Turkey)
3. A New Surgical Approach to Internal Thoracic Artery Spasm Treatment Using the Radial and Gastroepiploic Arteries during Coronary Artery Bypass Graft, Ö. F. Doğan (Turkey)
4. Investigation of the vasorelaxant effects of moxonidine and its relaxation mechanism on the human radial artery when used as a coronary bypass graft, B. Saraç (Turkey)
5. Is preoperative eosinopenia an independent predictor of early mortality for coronary artery bypass surgery?, Ö. Korkmaz (Turkey)
6. Heart string reduces stroke rate and enables complete revascularization in off pump coronary artery bypass graft surgery, D. Odavic (Switzerland)
7. Successful surgical revascularization strategy in a patient with serious left main coronary artery disease and low ejection fraction in third hour of myocardial infarction with on going chest pain, U. Yetkin (Turkey)
8. Should We Wait 5 Days After Discontinuation of Dual Antiplatelet Therapy in Patients Who Need Urgent Coronary artery bypass grafting, S. KAcar (Serbia)
9. A Journey of a Thousand Miles Begins with a Single Step, I. Bilbija (Serbia)
2. Outcomes of On-pump Beating Heart versus Traditional On-Pump Coronary Artery By-Pass Grafting Surgey in end-stage renal disease patients, Ö. F. Doğan (Turkey)
3. A New Surgical Approach to Internal Thoracic Artery Spasm Treatment Using the Radial and Gastroepiploic Arteries during Coronary Artery Bypass Graft, Ö. F. Doğan (Turkey)
4. Investigation of the vasorelaxant effects of moxonidine and its relaxation mechanism on the human radial artery when used as a coronary bypass graft, B. Saraç (Turkey)
5. Is preoperative eosinopenia an independent predictor of early mortality for coronary artery bypass surgery?, Ö. Korkmaz (Turkey)
6. Heart string reduces stroke rate and enables complete revascularization in off pump coronary artery bypass graft surgery, D. Odavic (Switzerland)
7. Successful surgical revascularization strategy in a patient with serious left main coronary artery disease and low ejection fraction in third hour of myocardial infarction with on going chest pain, U. Yetkin (Turkey)
8. Should We Wait 5 Days After Discontinuation of Dual Antiplatelet Therapy in Patients Who Need Urgent Coronary artery bypass grafting, S. KAcar (Serbia)
9. A Journey of a Thousand Miles Begins with a Single Step, I. Bilbija (Serbia)
10. Bilateral Sceletonized IMAs for Myocardial Revascularization in Elderly Patients, Z. Jonjev (Serbia)
09:00 - 10:30Cardiovascular Resident Forum
Hall Aegan
Moderators:M. Planinc (Croatia), N.Kontopodis (Greece), M.Sladojevic (Serbia)
1. What is the Optimal Mode of Mechanical Support in Transplanted Patient with Acute Graft Failure?, M. Monteagudo Vela, MD (Spain)
2. How to Handle the Big MAC: Pitfalls and Safeguards During Mitral Valve Replacement,C. Ciobanu, MD (Romania)
3. Performing Coronary Surgery in 21st Century - Should We Do More Arterial Grafts? P. Vukovic, (Serbia)
4. Current knowledge on EndoVascular Aneurysm Sealing (EVAS) with the Nellix device, M. Sladojevic, MD (Serbia)
5. Advancements in ArterioVenous access creation in complicated patients, C.Maturi (Italy)
6. Strategies to preserve internal iliac artery during Endovascular Aneurysm Repair (EVAR), K. Spanos, (Greece)
10:45 - 12:45Abstract session XI: MISCELANEOUS II Hall: Atlantic II
Moderators: M.Thielman (Germany), P. Milojevic (Serbia)
Key Note Lecture:Stanford type A acute aortic dissection in pregnancy P. Milojevic (Serbia)
1. Do surgical techniques make a difference in the treatment of tricuspid valve endocarditis in intravenous drug addicts?, R. Guo (United Kingdom)
2. Performance of EuroSCORE 2 and logistic EuroSCORE in patients with native valve endocarditis, D. Unic (Croatia)
3. One year follow up in patients who underwent myectomy due to septal hypertrophy, F. López Valdiviezo (Spain)
4. Utilizing topical negative pressure in treatment of posternotomy wounds, F. Rudman (Croatia)
5. Computed tomography fistulography as a tool for planning treatment of sternal osteomyelitis, F. Rudman (Croatia)
6. Validation of EuroSCORE II performances on a single-centre, contemporary cardiac surgery cohort of 5732 patients, D. Nezic (Serbia)
7. Predictive factors of 12-year survival following valve surgery for infective endocarditis, C. Corazzari (Italy)
8. The “Jung” variable as predictor of in-hospital outcome in patients presenting with acute st elevated myocardial infarction after primary percutaneous coronary intervention, M. Sladojevic (Serbia)
9. Impact of negative blood cultures on outcome after surgery for acute infective endocarditis, E.Sportelli (Italy)
1. Do surgical techniques make a difference in the treatment of tricuspid valve endocarditis in intravenous drug addicts?, R. Guo (United Kingdom)
2. Performance of EuroSCORE 2 and logistic EuroSCORE in patients with native valve endocarditis, D. Unic (Croatia)
3. One year follow up in patients who underwent myectomy due to septal hypertrophy, F. López Valdiviezo (Spain)
4. Utilizing topical negative pressure in treatment of posternotomy wounds, F. Rudman (Croatia)
5. Computed tomography fistulography as a tool for planning treatment of sternal osteomyelitis, F. Rudman (Croatia)
6. Validation of EuroSCORE II performances on a single-centre, contemporary cardiac surgery cohort of 5732 patients, D. Nezic (Serbia)
7. Predictive factors of 12-year survival following valve surgery for infective endocarditis, C. Corazzari (Italy)
8. The “Jung” variable as predictor of in-hospital outcome in patients presenting with acute st elevated myocardial infarction after primary percutaneous coronary intervention, M. Sladojevic (Serbia)
9. Impact of negative blood cultures on outcome after surgery for acute infective endocarditis, E.Sportelli (Italy)
Bilateral Talks
- Participants0
- Meetings Requested0
- Meetings Accepted0
Participants
-
Afghanistan 3 -
Albania 2 -
Armenia 1 -
Austria 5 -
Azerbaijan 5 -
Belarus 1 -
Belgium 4 -
Bosnia-Herzegovina 18 -
Brazil 7 -
Bulgaria 5 -
Canada 1 -
China 3 -
Congo-Kinshasa(Zaire) 3 -
Croatia 24 -
Czech Republic 7 -
Egypt 9 -
Estonia 1 -
France 6 -
Germany 20 -
Ghana 1 -
Greece 16 -
Iran 2 -
Italy 44 -
Japan 10 -
Kazakhstan 7 -
Kuwait 1 -
Macedonia 10 -
Malta 4 -
Moldova 3 -
Montenegro 1 -
Netherlands 6 -
New Zealand 1 -
Nigeria 7 -
Norway 1 -
Palestine 1 -
Philippines 1 -
Poland 11 -
Portugal 3 -
Romania 21 -
Russian Federation 42 -
Saudi Arabia 2 -
Serbia 104 -
Slovakia 6 -
Slovenia 17 -
South Korea 8 -
Spain 12 -
Switzerland 4 -
Taiwan 2 -
Tunisia 4 -
Turkey 37 -
Ukraine 9 -
United Kingdom 12 -
USA 4 -
Uzbekistan 1 -
Venezuela 1 - Total of Participants541
Profile views
- Before Event277940
- After Event119819
Important dates
- 18.01.2016.Deadline for ABSTRACT SUBMISSION01.01.2016End of EARLY BIRD REGISTRATION21.04.2016 - Congress
Follow us
All pictures and ABSTRACT BOOK
 |
 |
 |